Skip to content

Clinical study of Rongqingbaohuashuan powder on patients with carotid atherosclerosis

Clinical study of Rongqingbaohuashuan powder on patients with carotid atherosclerosis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005121
Enrollment
Unknown
Registered
2021-08-02
Start date
2021-08-16
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia

Interventions

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Sign the informed consent form and be aged 40 to 65 years on the day; 2. Fasting low-density lipoprotein cholesterol (LDL-C) >=3.4mmol/L; 3. Fasting triglyceride <=5.6 mmol/L during screening; 4. Carotid ultrasound showed carotid atherosclerotic plaque.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to any ingredient in statin or Rongqingbaohua suppository powder food; 2. Those with a history of hypertension and diabetes and a definite diagnosis; 3. Rheumatic immune diseases, malignant tumors, etc.; 4. Various acute and chronic infectious diseases and acute metabolic disorders; 5. Chronic bronchitis, chronic obstructive pulmonary disease, etc.; 6. Liver function alanine aminotransferase (ALT) or aspartate aminotransferase (AST) or total bilirubin is higher than the upper limit of normal; 7. Creatine kinase (CK) is higher than the upper limit of normal; 8. Estimated glomerular filtration rate (eGFR) <= 90ml/min/1.73m2 (calculated by MDRD formula); 9. Those who are currently taking various lipid-lowering drugs (including Western medicines, Chinese patent medicines and other drugs and health care products with lipid-lowering effects).

Design outcomes

Primary

MeasureTime frame
Carotid atherosclerotic plaque;blood fat;

Countries

China

Contacts

Public ContactCheng Mei

Qilu Hospital of Shandong University

jncm65@163.com+86 18560082278

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026